BDBM159295 US10093663, Example 9-1::US9682968, Example-9-1

SMILES Cc1cc(Cl)c(CN2CCCCC2c2ccc(cc2)C(N)=O)c2cc[nH]c12

InChI Key InChIKey=VVYYBWFVWGOHGG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 159295   

TargetComplement factor B(Human)
Novartis

US Patent
LigandPNGBDBM159295(US9682968, Example-9-1 | US10093663, Example 9-1)
Affinity DataIC50: 2nMAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 uM), recombinant human complement factor B (expressed in drosophila cells and purified us...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2018
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandPNGBDBM159295(US9682968, Example-9-1 | US10093663, Example 9-1)
Affinity DataIC50: 2.00E+3nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent